{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:39:06Z","timestamp":1790422746496,"version":"4.1.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00223-018-0399-z","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T14:26:04Z","timestamp":1518618364000},"page":"111-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders"],"prefix":"10.1007","volume":"103","author":[{"given":"Jordi","family":"Bover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"L\u00f3pez-B\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara","family":"daSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"issue":"6","key":"399_CR1","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.semnephrol.2014.09.006","volume":"34","author":"S Mazzaferro","year":"2014","unstructured":"Mazzaferro S, Tartaglione L, Rotondi S, Bover J, Goldsmith D, Pasquali M (2014) News on biomarkers in CKD-MBD. Semin Nephrol 34(6):598\u2013611","journal-title":"Semin Nephrol"},{"issue":"9","key":"399_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/ki.2008.26","volume":"73","author":"K Lomashvili","year":"2008","unstructured":"Lomashvili K, Garg P, Narisawa S, Millan JL, O\u2019neill WC (2008) Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 73(9):1024\u20131030","journal-title":"Kidney Int"},{"issue":"9","key":"399_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ki.2008.104","volume":"73","author":"M Schoppet","year":"2008","unstructured":"Schoppet M, Shanahan CM (2008) Role for alkaline phosphatase as an inducer of vascular calcification in renal failure? Kidney Int 73(9):989\u2013991","journal-title":"Kidney Int"},{"key":"399_CR4","first-page":"363","volume":"35","author":"D Schibler","year":"1968","unstructured":"Schibler D, Russell RGG, Fleisch H (1968) Inhibition by pyrophosphate and poly-phosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci 35:363\u2013372","journal-title":"Clin Sci"},{"issue":"5","key":"399_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.5301\/jn.5000187","volume":"25","author":"GM London","year":"2012","unstructured":"London GM (2012) Bone-vascular cross-talk. J Nephrol 25(5):619\u2013625","journal-title":"J Nephrol"},{"issue":"9","key":"399_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1080\/14656566.2016.1182155","volume":"17","author":"J Bover","year":"2016","unstructured":"Bover J, Ure\u00f1a-Torres P, Lloret MJ, Ruiz-Garc\u00eda C, DaSilva I, Diaz-Encarnacion M, Mercado C, Mateu S, Fernandez E, Ballarin J (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opin Pharmacother 17(9):1247\u20131258","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"399_CR7","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1080\/14656566.2016.1182985","volume":"17","author":"J Bover","year":"2016","unstructured":"Bover J, Ure\u00f1a-Torres P, Lloret MJ, Ruiz C, DaSilva I, Diaz-Encarnacion MM, Mercado C, Mateu S, Fern\u00e1ndez E, Ballarin J (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opin Pharmacother 17(10):1363\u20131373","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"399_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2215\/CJN.06091108","volume":"4","author":"R Shantouf","year":"2009","unstructured":"Shantouf R, Kovesdy CP, Kim Y, Ahmadi N, Luna A, Luna C, Rambod M, Nissenson AR, Budoff MJ, Kalantar-Zadeh K (2009) Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol 4(6):1106\u20131114","journal-title":"Clin J Am Soc Nephrol"},{"key":"399_CR9","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/ndt\/gfu086","volume":"29","author":"W Lau","year":"2014","unstructured":"Lau W, Kalantar-Zadeh K (2014) Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures. Nephrol Dial Transplant 29:1450\u20131452","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"399_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0009-8981(90)90031-M","volume":"186","author":"H Harris","year":"1990","unstructured":"Harris H (1990) The human alkaline phosphatases: what we know and what we don\u2019t know. Clin Chim Acta 186(2):133\u2013150","journal-title":"Clin Chim Acta"},{"issue":"5","key":"399_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","volume":"45","author":"C Linder","year":"2009","unstructured":"Linder C, Narisawa S, Mill\u00e1n L, Magnusson P (2009) Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 45(5):987\u2013993","journal-title":"Bone"},{"issue":"5","key":"399_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","volume":"41","author":"R Bervoets","year":"2003","unstructured":"Bervoets R, Spasovski B, Behets J, Dams G, Polenakovic H, Zafirovska K, D\u2019Haese, C (2003) Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis 41(5):997\u20131007","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"399_CR13","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","volume":"13","author":"G Coen","year":"1998","unstructured":"Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Sardella D (1998) Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 13(9):2294\u20132302","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"399_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000335303","volume":"1","author":"O Ortega","year":"2011","unstructured":"Ortega O, Rodriguez I, Hinostroza J, Laso N, Callejas R, Gallar P, Vigil A (2011) Serum alkaline phosphatase levels and left ventricular diastolic dysfunction in patients with advanced chronic kidney disease. Nephron Extra 1(1):283\u2013291","journal-title":"Nephron Extra"},{"issue":"7862","key":"399_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(74)90515-7","volume":"303","author":"AW Walker","year":"1974","unstructured":"Walker AW (1974) Increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis. Lancet 303(7862):866\u2013867","journal-title":"Lancet"},{"issue":"6","key":"399_CR16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/clinchem\/37.6.783","volume":"37","author":"E Broe De","year":"1991","unstructured":"De Broe E, Van Hoof O (1991) Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin Chem 37(6):783\u2013784","journal-title":"Clin Chem"},{"issue":"6","key":"399_CR17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/clinchem\/37.6.815","volume":"37","author":"L Tibi","year":"1991","unstructured":"Tibi L, Chabra C, Sweeting M, Winney J, Smith F (1991) Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin Chem 37(6):815\u2013820","journal-title":"Clin Chem"},{"issue":"3","key":"399_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1373\/clinchem.2004.045831","volume":"51","author":"H Zetterberg","year":"2005","unstructured":"Zetterberg H (2005) Increased serum concentrations of intestinal alkaline phosphatase in peritoneal dialysis. Clin Chem 51(3):675\u2013676","journal-title":"Clin Chem"},{"issue":"7","key":"399_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrneph.2017.60","volume":"13","author":"M Haarhaus","year":"2017","unstructured":"Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P (2017) Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nature Rev Nephrol 13(7):429\u2013442","journal-title":"Nature Rev Nephrol"},{"issue":"6","key":"399_CR20","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"P Ure\u00f1a Torres","year":"1999","unstructured":"Ure\u00f1a Torres P, de Vernejoul C (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55(6):2141\u20132156","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","volume":"7","author":"P Ure\u00f1a Torres","year":"1996","unstructured":"Ure\u00f1a Torres P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC (1996) Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7(3):506\u2013512","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"399_CR22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/ndt\/11.6.1065","volume":"11","author":"M Couttenye","year":"1996","unstructured":"Couttenye M, D\u2019Haese C, Van Hoof O, Lemoniatou E, Goodman W, Verpooten A, De Broe E (1996) Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 11(6):1065\u20131072","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"399_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"J Behets","year":"2015","unstructured":"Behets J, Spasovski G, Sterling R, Goodman G, Spiegel M, De Broe E, D\u2019haese PC (2015) Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87(4):846\u2013856","journal-title":"Kidney Int"},{"issue":"4","key":"399_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, Rojas E (2016) Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67(4):559\u2013566","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"399_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","volume":"77","author":"M Ueda","year":"2005","unstructured":"Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77(10):1130\u20131139","journal-title":"Life Sci"},{"issue":"2","key":"399_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ki.1994.276","volume":"46","author":"J Bover","year":"1994","unstructured":"Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ (1994) The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia. Kidney Int 46(2):310\u2013317","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S8756-3282(99)00169-6","volume":"25","author":"J Bover","year":"1999","unstructured":"Bover J, Jara A, Trinidad P, Rodriguez M, Felsenfeld A (1999) Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus. Bone 25(3):279 \u2013 85","journal-title":"Bone"},{"key":"399_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2012.12.009","volume":"417","author":"P Delanaye","year":"2013","unstructured":"Delanaye P, Dubois E, Jouret F, Krzesinski M, Moranne O, Cavalier E (2013) Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Clin Chim Acta 417:35\u201338","journal-title":"Clin Chim Acta"},{"key":"399_CR29","first-page":"2103","volume-title":"Brenner and Rector\u00b4s \u201cThe Kidney\u201d","author":"F Llach","year":"2000","unstructured":"Llach F, Bover J (2000). Renal Osteodystrophies. Brenner BM, editor. Brenner and Rector\u00b4s \u201cThe Kidney\u201d. 6th\u00a0edn. Filadelfia. W.B. Saunders Company. pp\u00a02103\u20132186"},{"issue":"6","key":"399_CR30","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Ure\u00f1a Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184\u20131190","journal-title":"Kidney Int"},{"issue":"1","key":"399_CR31","first-page":"63","volume":"31","author":"JM Evanson","year":"1966","unstructured":"Evanson JM (1966) The response to the infusion of parathyroid extract in hypocalcaemic states. Clin Sci 31(1):63\u201375","journal-title":"Clin Sci"},{"issue":"6","key":"399_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ki.1976.60","volume":"9","author":"S Massry","year":"1976","unstructured":"Massry S, Stein R, Garty J, Arieff A, Coburn J, Norman A, Friedler R (1976) Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3. Kidney Int 9(6):467\u2013474","journal-title":"Kidney Int"},{"issue":"2","key":"399_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/jcem-41-2-339","volume":"41","author":"F Llach","year":"1975","unstructured":"Llach F, Massry S, Singer F, Kurokawa K, Kaye J, Coburn J (1975, August) Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure. A possible cause for secondary hyperparathyroidism. J Clin Endocrinol Metab 41(2):339\u2013345","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"399_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ki.1985.48","volume":"27","author":"L Wilson","year":"1985","unstructured":"Wilson L, Felsenfeld A, Drezner MK, Llach F (1985). Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D. Kidney Int 27(3):565\u2013573","journal-title":"Kidney Int"},{"issue":"4","key":"399_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/ki.1994.129","volume":"45","author":"J Bover","year":"1994","unstructured":"Bover J, Rodriguez M, Trinidad P, Jara A, Martinez ME, Machado L, Llach F, Felsenfeld AJ (1994) Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat. Kidney Int 1994;45(4):953 \u2013 61","journal-title":"Kidney Int"},{"issue":"5","key":"399_CR36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ki.1991.118","volume":"39","author":"L Andress","year":"1991","unstructured":"Andress L, Howard A, Birnbaum S (1991) Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma. Kidney Int 39(5):942\u2013945","journal-title":"Kidney Int"},{"issue":"s2","key":"399_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2362.2006.01663.x","volume":"36","author":"S Mathew","year":"2006","unstructured":"Mathew S, Davies M, Lund R, Saab G, Hruska A (2006) Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur J Clin Invest 36(s2):43\u201350","journal-title":"Eur J Clin Invest"},{"issue":"1 Pt 1","key":"399_CR38","first-page":"E139-146","volume":"272","author":"A Portale","year":"1997","unstructured":"Portale A, Lonergan E, Tanney D, Halloran B (1997) Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men. Am J Physiol 272(1 Pt 1):E139-146","journal-title":"Am J Physiol"},{"issue":"2","key":"399_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/ki.1994.79","volume":"45","author":"P Ure\u00f1a","year":"1994","unstructured":"Ure\u00f1a P, Kubrusly M, Mannstadt M, Hruby M, Trinh MM, Silve C, Lacour B, Abou-Samra AB, Segre GV, Dr\u00fceke T (1994) The renal PTH\/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45(2):605 \u2013 11","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ki.2009.464","volume":"77","author":"H Galitzer","year":"2010","unstructured":"Galitzer H, Ben-Dov Z, Silver J, Naveh-Many T (2010) Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 77(3):211\u2013218","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ki.2009.414","volume":"77","author":"H Komaba","year":"2010","unstructured":"Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, Tsugawa N, Okano T, Kitazawa R, Fukagawa M, Kita T (2010) Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 77(3):232\u2013238","journal-title":"Kidney Int"},{"issue":"4","key":"399_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","volume":"55","author":"A Brown","year":"1999","unstructured":"Brown A, Ritter C, Finch J, Slatopolsky E (1999) Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 55(4):1284\u20131292","journal-title":"Kidney Int"},{"issue":"1","key":"399_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ki.1989.3","volume":"35","author":"A Brown","year":"1989","unstructured":"Brown A, Dusso A, Lopez-Hilker S, Lewis-Finch J, Grooms P, Slatopolsky E (1989) 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 35(1):19\u201323","journal-title":"Kidney Int"},{"issue":"7","key":"399_CR44","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1210\/endo.136.7.7789335","volume":"136","author":"A Mithal","year":"1995","unstructured":"Mithal A, Kifor O, Kifor I, Vassilev P, Butters R, Krapcho K, Simin R, Fuller F, Hebert S, Brown E (1995) The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2 + is associated with marked reduction in the expression of extracellular Ca(2+)-sensing receptor messenger ribonucleic acid and protein. Endocrinology 136(7):3087\u20133092","journal-title":"Endocrinology"},{"issue":"5","key":"399_CR45","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","volume":"60","author":"C Ritter","year":"2001","unstructured":"Ritter C, Finch J, Slatopolsky E, Brown A (2001, November) Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int 60(5):1737\u20131744","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR46","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1172\/JCI116720","volume":"92","author":"N Fukuda","year":"1993","unstructured":"Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92(3):1436\u20131443","journal-title":"J Clin Invest"},{"issue":"3","key":"399_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1152\/ajprenal.00061.2002","volume":"283","author":"J Silver","year":"2002","unstructured":"Silver J, Kilav R, Naveh-Many T (2002) Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 283(3):367\u2013376","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"399_CR48","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1210\/en.2011-1770","volume":"153","author":"P Rom\u00e1n-Garc\u00eda","year":"2012","unstructured":"Rom\u00e1n-Garc\u00eda P, Carrillo-L\u00f3pez N, Naves-D\u00edaz M, Rodr\u00edguez I, Ortiz A, Cannata-And\u00eda B (2012) Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats. Endocrinology 153(4):1627\u20131637","journal-title":"Endocrinology"},{"key":"399_CR49","doi-asserted-by":"publisher","first-page":"563\u2014568","DOI":"10.1172\/JCI110067","volume":"67","author":"RA DeFronzo","year":"1981","unstructured":"DeFronzo RA, Alvestrand A, Smith D, Hendler R (1981) Insulin resistance in uremia. J Clin Invest 67:563\u2014568","journal-title":"J Clin Invest"},{"key":"399_CR50","first-page":"539\u2014544","volume":"0","author":"WF Blum","year":"1991","unstructured":"Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls (1991) Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5 0:539\u2014544","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"399_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ki.2014.425","volume":"87","author":"M Ketteler","year":"2015","unstructured":"Ketteler M, Elder G, Evenepoel P, Ix J, Jamal S, Lafage-Proust M, Shroff R, Thadhani R, Tonelli M, Kasiske B, Wheeler D, Leonard M (2015) Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a kidney disease: improving global outcomes controversies conference. Kidney Int 87(3):502\u2013528","journal-title":"Kidney Int"},{"issue":"6","key":"399_CR53","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","volume":"34","author":"J Bover","year":"2014","unstructured":"Bover J, Ure\u00f1a Torres P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, Bosch RJ (2014) Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol 34(6):626\u2013640","journal-title":"Semin Nephrol"},{"issue":"1","key":"399_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","volume":"66","author":"M Haarhaus","year":"2015","unstructured":"Haarhaus M, Monier-Faugere M, Magnusson P, Malluche H (2015) Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Am J Kidney Dis 66(1):99\u2013105","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"399_CR55","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00223-001-1137-4","volume":"71","author":"P Magnusson","year":"2002","unstructured":"Magnusson P, Farley R (2002) Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif Tissue Int 71(6):508\u2013518","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"399_CR56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","volume":"45","author":"C Halling Linder","year":"2009","unstructured":"Halling Linder C, Narisawa S, Mill\u00e1n J, Magnusson P (2009) Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 45(5):987\u2013993","journal-title":"Bone"},{"issue":"1","key":"399_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","volume":"60","author":"P Magnusson","year":"2001","unstructured":"Magnusson P, Sharp A, Magnusson M, Risteli J, Davie W, Larsson L (2001) Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 60(1):257\u2013265","journal-title":"Kidney Int"},{"issue":"11","key":"399_CR58","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00467-006-0231-2","volume":"21","author":"D Swolin-Eide","year":"2006","unstructured":"Swolin-Eide D, Hansson S, Larsson L, Magnusson P (2006) The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 21(11):1723\u20131729","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"399_CR59","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/ndt\/gfp300","volume":"24","author":"M Haarhaus","year":"2009","unstructured":"Haarhaus M, Fernstr\u00f6m A, Magnusson M, Magnusson P (2009) Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease. Nephrol Dial Transplant 24(11):3382\u20133389","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"399_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000346161","volume":"50","author":"M Haarhaus","year":"2013","unstructured":"Haarhaus M, Arnqvist H, Magnusson P (2013) Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform. J Vasc Res 50(2):167\u2013174","journal-title":"J Vasc Res"},{"issue":"6","key":"399_CR61","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.clinbiochem.2012.01.018","volume":"45","author":"G Jean","year":"2012","unstructured":"Jean G, Souberbielle J, Zaoui E, Lorriaux C, Mayor B, Hurot J, Deleaval P, Chazot C (2012) Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease. Clin Biochem 45(6):436\u2013439","journal-title":"Clin Biochem"},{"issue":"6","key":"399_CR62","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"P Ure\u00f1a-Torres","year":"1999","unstructured":"Ure\u00f1a-Torres P, De Vernejoul M (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55(6):2141\u20132156","journal-title":"Kidney Int"},{"issue":"2","key":"399_CR63","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ki.2010.356","volume":"79","author":"S Damera","year":"2011","unstructured":"Damera S, Raphael L, Baird C, Cheung K, Greene T, Beddhu S (2011) Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. Kidney Int 79(2):228\u2013233","journal-title":"Kidney Int"},{"issue":"7","key":"399_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0132822","volume":"10","author":"K Kunutsor","year":"2015","unstructured":"Kunutsor K, Bakker J, Kootstra-Ros E, Gansevoort T, Gregson J, Dullaart P (2015) Serum alkaline phosphatase and risk of incident cardiovascular disease: interrelationship with high sensitivity C-reactive protein. PLoS ONE 10(7):1\u201316","journal-title":"PLoS ONE"},{"key":"399_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2215\/CJN.12031111","volume":"8","author":"R Filipowicz","year":"2013","unstructured":"Filipowicz R, Greene T, Wei G, Cheung A, Raphael K, Baird B, Beddhu S (2013) Associations of Serum Skeletal Alkaline Phosphatase with Elevated C-Reactive Protein and Mortality. Clin J Am Soc Nephrol 8:26\u201332","journal-title":"Clin J Am Soc Nephrol"},{"key":"399_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor D, Kovesdy C, Kilpatrick R, Shinaberger C, McAllister C, Budoff M, Salusky I, Kopple J (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771\u2013780","journal-title":"Kidney Int"},{"key":"399_CR67","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ki.2008.248","volume":"74","author":"M Blayney","year":"2008","unstructured":"Blayney M, Pisoni P, Bragg-Gresham J, Bommer J, Piera L, Saito A, Akiba T, Keen M, Young E, Port F (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 74:655\u2013663","journal-title":"Kidney Int"},{"key":"399_CR68","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/ndt\/gfq144","volume":"25","author":"C Kovesdy","year":"2010","unstructured":"Kovesdy C, Ureche V, Lu J, Kalantar-Zadeh K (2010) Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant 25:3003\u20133011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"399_CR69","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1053\/j.ajkd.2013.04.012","volume":"62","author":"J Taliercio","year":"2013","unstructured":"Taliercio J, Schold J, Simon J, Arrigain S, Tang A, Saab S, Nally J, Navaneethan S (2013) Prognostic importance of serum alkaline phosphatase in CKD stages 3\u20134 in a clinical population. Am J Kidney Dis 62(4):703\u2013710","journal-title":"Am J Kidney Dis"},{"key":"399_CR70","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2215\/CJN.01910212","volume":"7","author":"M Molnar","year":"2012","unstructured":"Molnar M, Kovesdy C, Mucsi I, Salusky I, Kalantar-Zadeh K (2012) Association of pre\u2013kidney transplant markers of mineral and bone disorder with post-transplant outcomes. Clin J Am Soc Nephrol 7:1859\u20131871","journal-title":"Clin J Am Soc Nephrol"},{"key":"399_CR71","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2215\/CJN.01560309","volume":"4","author":"S Beddhu","year":"2009","unstructured":"Beddhu S, Ma X, Baird B, Cheung A, Greene T (2009) Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol 4:1805\u20131810","journal-title":"Clin J Am Soc Nephrol"},{"key":"399_CR72","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3747\/pdi.2013.00110","volume":"34","author":"C Rhee","year":"2014","unstructured":"Rhee C, Molnar M, Lau W, Ravel V, Kovesdy C, Mehrotra R, Kalantar\u2013Zadeh K (2014) Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int 34:732\u2013748","journal-title":"Perit Dial Int"},{"key":"399_CR73","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/ndt\/gft290","volume":"28","author":"P Lertdumrongluk","year":"2013","unstructured":"Lertdumrongluk P, Lau W, Park J, Rhee C, Kovesdy C, Kalantar-Zadeh K (2013) Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant 28:2535\u20132545","journal-title":"Nephrol Dial Transplant"},{"issue":"5\u20136","key":"399_CR74","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lfs.2011.11.006","volume":"90","author":"I Kobayashi","year":"2012","unstructured":"Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M (2012) Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients. Life Sci 90(5\u20136):212\u2013218","journal-title":"Life Sci"},{"issue":"18","key":"399_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000000106","volume":"93","author":"J Chang","year":"2014","unstructured":"Chang J, Feng Y, Peng Y, Hsu S, Pai M, Chen H, Wu H, Yang J (2014) Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients. Medicine (Baltimore) 93(18):1\u20138","journal-title":"Medicine (Baltimore)"},{"key":"399_CR76","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw412","author":"K Sumida","year":"2017","unstructured":"Sumida K, Molnar M, Potukuchi P, Thomas F, Lu J, Obi Y, Rhee C, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy C (2017) Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfw412 [E-pub ahead of print]","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"399_CR77","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.109.851873","volume":"120","author":"M Tonelli","year":"2009","unstructured":"Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed M, Wiebe N, Muntner P (2009) Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120(18):1784\u20131792","journal-title":"Circulation"},{"issue":"7","key":"399_CR78","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.2215\/CJN.10091110","volume":"6","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Verduijn M, Pilz S, Krediet R, Dekker F, Wanner C, Ketteler M, Boeschoten E, Brandenburg V, NECOSAD Study Group (2011). Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Sc Nephrol 6 (7): 1752\u20131759","journal-title":"Clin J Am Sc Nephrol"},{"issue":"8","key":"399_CR79","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","volume":"29","author":"Y Maruyama","year":"2014","unstructured":"Maruyama Y, Taniguchi M, Kazama J, Yokoyama K, Hosoya T, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y (2014) A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant 29(8):1532\u20131538","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"399_CR80","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2215\/CJN.06091108","volume":"4","author":"R Shantouf","year":"2009","unstructured":"Shantouf R, Kovesdy C, Kim Y, Ahmadi N, Luna A, Luna C, Rambod M, Nissenson A, Budoff M, Kalantar-Zadeh K (2009) Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol 4(6):1106\u20131114","journal-title":"Clin J Am Soc Nephrol"},{"key":"399_CR81","doi-asserted-by":"crossref","unstructured":"Chen J, Mohler E, Xie D, Shlipak M, Townsend R, Appel L, Ojo A, Schreiber M, Nessel L, Zhang X, Raj D, Strauss L, Lora C, Rahman M, Hamm L, He J, CRIC Study Investigators. (2016). Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease. Nephrol Dial Transplant 31 (7): 1145\u20131151","DOI":"10.1093\/ndt\/gfv418"},{"issue":"2","key":"399_CR82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1542-4758.2009.00430.x","volume":"14","author":"J Park","year":"2010","unstructured":"Park J, Kovesdy C, Duong U, Streja E, Rambod M, Nissenson A, Sprague S, Kalantar-Zadeh K (2010) Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int 14(2):182\u2013192","journal-title":"Hemodial Int"},{"issue":"5","key":"399_CR83","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.ajkd.2008.12.040","volume":"53","author":"K Kalantar-Zadeh","year":"2009","unstructured":"Kalantar-Zadeh K, Lee G, Miller J, Streja E, Jing J, Robertson J, Kovesdy C (2009) Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 53(5):823\u2013834","journal-title":"Am J Kidney Dis"},{"key":"399_CR84","first-page":"1","volume":"1","author":"A Bergman","year":"2016","unstructured":"Bergman A, Qureshi A, Haarhaus M, Lindholm B, Barany P, Heimburger O, Stenvinkel P, Anderstam B (2016) Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis. J Nephrol 1:1\u20138","journal-title":"J Nephrol"},{"issue":"11","key":"399_CR85","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2008010014","volume":"19","author":"D Regidor","year":"2008","unstructured":"Regidor D, Kovesdy C, Mehrotra R, Rambod M, Jing J, McAllister C, Van Wyck D, Kopple J, Kalantar-Zadeh K (2008) Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19(11):2193 \u2013 203","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"399_CR86","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2011","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler D, ARO Investigators (2011). Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26(6): 1948\u20131955","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"399_CR87","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","volume":"26","author":"M Naves","year":"2011","unstructured":"Naves M, Passlick J, Guinsburg A, Marelli C, Fern\u00e1ndez J, Rodr\u00edguez D, Cannata J (2011) Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant 26(6):1938\u20131947","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"399_CR88","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fern\u00e1ndez-Mart\u00edn","year":"2015","unstructured":"Fern\u00e1ndez-Mart\u00edn JL, Mart\u00ednez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Gorriz JL, Rutkowski B, Ferreira A, Bos WJ, Covic A, Rodr\u00edguez-Garc\u00eda M, S\u00e1nchez JE, Rodr\u00edguez-Puyol D, Cannata-Andia JB; COSMOS group (2015). Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30(9):1542\u20131551","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"399_CR89","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/hdi.12190","volume":"18","author":"W Lau","year":"2014","unstructured":"Lau W, Kalantar-Zadeh K, Kovesdy C, Mehrotra R (2014) Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease? Hemodial Int 18(4):720\u2013724","journal-title":"Hemodial Int"},{"issue":"11","key":"399_CR90","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1359\/jbmr.080610","volume":"23","author":"A Fahrleitner-Pammer","year":"2008","unstructured":"Fahrleitner-Pammer A, Herberth J, Browning S, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche H (2008) Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 23(11):1850\u20131858","journal-title":"J Bone Miner Res"},{"issue":"7","key":"399_CR91","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1210\/jc.2010-2878","volume":"96","author":"C Robinson-Cohen","year":"2011","unstructured":"Robinson-Cohen C, Katz R, Hoofnagle A, Cauley J, Furberg C, Robbins J, Chen Z, Siscovick D, de Boer I, Kestenbaum B (2011) Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. J Clin Endocrinol Metab 96(7):2186\u20132193","journal-title":"J Clin Endocrinol Metab"},{"key":"399_CR92","first-page":"1","volume":"18","author":"C David","year":"2016","unstructured":"David C, Bover J, Voiculet C, Peride I, Petcu L, Niculae A, Covic A, Checherita I (2016) Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study. Int Urol Nephrol 18:1\u201312","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"399_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2013-004275","volume":"4","author":"J Beige","year":"2014","unstructured":"Beige J, Wendt R, Girndt M, Queck K, Fiedler R, Jehle P (2014) Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis. BMJ Open 4(2):1\u20137","journal-title":"BMJ Open"},{"issue":"2","key":"399_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000444890","volume":"43","author":"M Soohoo","year":"2016","unstructured":"Soohoo M, Feng M, Obi Y, Streja E, Rhee C, Lau W, Wang J, Ravel V, Brunelli S, Kovesdy C, Kalantar-Zadeh K (2016) Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol 43(2):85\u201396","journal-title":"Am J Nephrol"},{"key":"399_CR95","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/hupa.2003.72","volume":"34","author":"J Qiao","year":"2003","unstructured":"Qiao J, Mertens R, Fishbein M, Geller SA (2003) Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: Morphologic evidence of enchondral ossification. Human Pathol 34:402\u2013407","journal-title":"Human Pathol"},{"key":"399_CR96","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"R Shroff","year":"2008","unstructured":"Shroff R, McNair R, Figg N, Skepper J, Schurgers L, Gupta A, Hiorns M, Donald A, Deanfield J, Rees L, Shanahan C (2008) Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis. Circulation 118:748\u20131757","journal-title":"Circulation"},{"key":"399_CR97","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ki.2009.83","volume":"75","author":"M El-Abbadi","year":"2009","unstructured":"El-Abbadi M, Pai A, Leaf E, Yang H, Bartley B, Quan K, Ingalls C, Liao H, Giachelli C (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75:1297\u20131307","journal-title":"Kidney Int"},{"issue":"5","key":"399_CR98","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1152\/ajpheart.00455.2009","volume":"297","author":"R Nakano-Kurimoto","year":"2009","unstructured":"Nakano-Kurimoto R, Ikeda K, Uraoka M, Nakagawa Y, Yutaka K, Koide M, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H (2009) Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiology Heart Circ Physiology 297(5):1673\u20131684","journal-title":"Am J Physiology Heart Circ Physiology"},{"issue":"5","key":"399_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0019595","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, Mackenzie N, Mill\u00e1n J, Farquharson C, MacRae V (2011) The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE 6(5):1\u201310","journal-title":"PLoS ONE"},{"issue":"1","key":"399_CR100","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/01.RES.0000026421.61398.F2","volume":"91","author":"A Shioi","year":"2002","unstructured":"Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circulation Res 91(1):9\u201316","journal-title":"Circulation Res"},{"issue":"5","key":"399_CR101","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jbmr.2420","volume":"30","author":"C Sheen","year":"2015","unstructured":"Sheen C, Kuss P, Narisawa S, Yadav M, Nigro J, Wang W, Chhea T, Sergienko E, Kapoor K, Jackson M, Hoylaerts M, Pinkerton A, O\u2019Neill W, Mill\u00e1n J (2015) Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 30(5):824\u2013836","journal-title":"J Bone Miner Res"},{"issue":"12","key":"399_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.115.002499","volume":"4","author":"Y Savinov","year":"2015","unstructured":"Savinov Y, Salehi M, Yadav C, Radichev I, Mill\u00e1n L, Savinova V (2015) Transgenic overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in vascular endothelium results in generalized arterial calcification. J Am Heart Assoc 4(12):1\u201313","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"399_CR103","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ki.2008.104","volume":"73","author":"M Schoppet","year":"2008","unstructured":"Schoppet M, Shanahan M (2008) Role for alkaline phosphatase as an inducer of vascular calcification in renal failure? Kidney Int 73(9):989\u2013991","journal-title":"Kidney Int"},{"issue":"9","key":"399_CR104","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.1276205","volume":"19","author":"M Murshed","year":"2005","unstructured":"Murshed M, Harmey D, Mill\u00e1n L, McKee D, Karsenty G (2005) Unique coexpression in osteoblast of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19(9):1093\u20131104","journal-title":"Genes Dev"},{"issue":"12","key":"399_CR105","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1161\/01.ATV.18.12.1964","volume":"18","author":"E Watson","year":"1998","unstructured":"Watson E, Parhami F, Shin V, Demer L (1998) Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioescler Thromb Vasc Biol 18(12):1964\u20131971","journal-title":"Arterioescler Thromb Vasc Biol"},{"key":"399_CR106","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000355807","volume":"39","author":"E Ishimura","year":"2014","unstructured":"Ishimura E, Okuno S, Okazaki H, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M (2014) Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients. Kidney Blood Press Res 39:299\u2013307","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"399_CR107","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00774-004-0528-9","volume":"22","author":"K Iba","year":"2004","unstructured":"Iba K, Takada J, Yamashita T (2004) The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab 22(6):594\u2013596","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"399_CR108","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ki.2013.521","volume":"85","author":"K Lomashvili","year":"2014","unstructured":"Lomashvili K, Narisawa S, Mill\u00e1n J, O\u2019Neill W (2014) Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int 85(6):1351\u20131356","journal-title":"Kidney Int"},{"key":"399_CR109","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mehy.2016.07.005","volume":"94","author":"P Joubert","year":"2016","unstructured":"Joubert P, Ketteler M, Salcedo C, Perell\u00f3 J (2016) Hypothesis: phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification. Med Hypotheses 94:89\u201392","journal-title":"Med Hypotheses"},{"key":"399_CR110","first-page":"1","volume":"30","author":"J Buades","year":"2016","unstructured":"Buades J, Sanch\u00eds P, Perell\u00f3 J, Grases F (2016) Plant phosphates, phytate and pathological calcifications in chronic kidney disease. Nefrolog\u00eda 30:1\u20139","journal-title":"Nefrolog\u00eda"},{"issue":"6","key":"399_CR111","first-page":"597","volume":"36","author":"J Bover","year":"2016","unstructured":"Bover J, Ure\u00f1a Torres P, G\u00f3rriz J, Lloret M, da Silva I, Ruiz-Garc\u00eda C, Chang P, Rodr\u00edguez M (2016) Cardiovascular calcifications in chronic kidney disease: potential therapeutic implications. Ballar\u00edn J Nefrolog\u00eda, 36(6):597\u2013608","journal-title":"Ballar\u00edn J"},{"key":"399_CR112","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.070714","volume":"11","author":"S Narisawa","year":"2007","unstructured":"Narisawa S, Harmey D, Yadav M, O\u2019Neill W, Hoylaerts M, Mill\u00e1n J (2007) Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res 11:1700\u20131710","journal-title":"J Bone Miner Res"},{"key":"399_CR113","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1021\/jm900383s","volume":"21","author":"R Dahl","year":"2009","unstructured":"Dahl R, Sergienko E, Su Y, Mostofi Y, Yang L, Simao A, Narisawa S, Brown B, Mangravita-Novo A, Vicchiarelli M, Smith L, O\u2019Neill W, Mill\u00e1n J, Cosford N (2009) Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J Medicinal Chemistry 21:6919\u20136925","journal-title":"J Medicinal Chemistry"},{"issue":"1","key":"399_CR114","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bmcl.2008.10.107","volume":"19","author":"S Sidique","year":"2009","unstructured":"Sidique S, Ardecky R, Su Y, Narisawa S, Brown B, Mill\u00e1n J, Sergienko E, Cosford N (2009) Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). Bioorg Med Chem Lett 19(1):222\u2013225","journal-title":"Bioorg Med Chem Lett"},{"key":"399_CR115","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1087057109338517","volume":"7","author":"E Sergienko","year":"2009","unstructured":"Sergienko E, Su Y, Chan X, Brown B, Hurder A, Narisawa S, Mill\u00e1n J (2009) Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action. J Biomol Screen 7:824\u2013837","journal-title":"J Biomol Screen"},{"key":"399_CR116","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3390\/molecules15053010","volume":"5","author":"T Chung","year":"2010","unstructured":"Chung T, Sergienko E, Mill\u00e1n J (2010) Assay format as a critical success factor for identification of novel inhibitor chemotypes of tissue-nonspecific alkaline phosphatase from high-throughput screening. Molecules 5:3010\u20133037","journal-title":"Molecules"},{"key":"399_CR117","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/nprot.2010.86","volume":"8","author":"E Sergienko","year":"2010","unstructured":"Sergienko E, Mill\u00e1n J (2010) High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action. Nat Protoc 8:1431\u20131439","journal-title":"Nat Protoc"},{"issue":"1","key":"399_CR118","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00223-017-0259-2","volume":"101","author":"C Linder","year":"2017","unstructured":"Linder C, Ek-Rylander B, Krumpel M, Norg\u00e5rd M, Narisawa S, Mill\u00e1n J, Andersson G, Magnusson P (2017) Bone alkaline phosphatase and tartrate-resistant acid phosphatase: potential co-regulators of bone mineralization. Calcif Tissue Int 101(1):92\u2013101","journal-title":"Calcif Tissue Int"},{"issue":"17","key":"399_CR119","doi-asserted-by":"publisher","first-page":"14044","DOI":"10.1074\/jbc.M008103200","volume":"276","author":"K Bostr\u00f6m","year":"2001","unstructured":"Bostr\u00f6m K, Tsao D, Shen S, Wang Y, Demer L (2001) Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1\/2 cells. J Biol Chem 276(17):14044\u201314052","journal-title":"J Biol Chem"},{"issue":"10","key":"399_CR120","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","volume":"18","author":"G Rawadi","year":"2003","unstructured":"Rawadi G, Vayssi\u00e8re B, Dunn F, Baron R, Roman-Roman S (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18(10):1842\u20131853","journal-title":"J Bone Miner Res"},{"issue":"1","key":"399_CR121","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jbmr.2606","volume":"31","author":"S Murali","year":"2016","unstructured":"Murali S, Roschger P, Zeitz U, Klaushofer K, Andrukhova O, Erben R (2016) FGF23 regulates bone mineralization in a 1,25(OH)2 D3 and Klotho-Independent manner. J Bone Miner Res 31(1):129\u2013142","journal-title":"J Bone Miner Res"},{"issue":"4","key":"399_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.1002427","volume":"14","author":"S Murali","year":"2016","unstructured":"Murali S, Andrukhova O, Clinkenbeard E, White K, Erben R (2016) Excessive Osteocytic FGF23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice. PLoS Biol 14(4):1\u201324","journal-title":"PLoS Biol"},{"key":"399_CR123","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1152\/ajpcell.00009.2015","volume":"3","author":"S Martin","year":"2015","unstructured":"Martin S, Lin H, Ejimadu C, Lee T (2015) Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts. Am J Physiol Cell Physiol 3:139\u2013147","journal-title":"Am J Physiol Cell Physiol"},{"key":"399_CR124","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1258\/000456306776865179","volume":"43","author":"A Ali","year":"2006","unstructured":"Ali A, Penny C, Paiker J, Psaras G, Ikram F, Crowther N (2006) The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue. Ann Clin Biochem 43:207\u2013213","journal-title":"Ann Clin Biochem"},{"key":"399_CR125","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","volume":"4","author":"S Sardiwal","year":"2013","unstructured":"Sardiwal S, Magnusson P, Goldsmith D, Lamb E (2013) Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis 4:810\u2013822","journal-title":"Am J Kidney Dis"},{"key":"399_CR126","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2013-2024","volume":"98","author":"C Cheung","year":"2013","unstructured":"Cheung C, Tan K, Lam K, Cheung B (2013) The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. J Clin Endocrinol Metab 98:3856\u20133863","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"399_CR127","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1073\/pnas.1220180110","volume":"110","author":"K Kaliannan","year":"2013","unstructured":"Kaliannan K, Hamarneh R, Economopoulos P, Nasrin S, Moaven O, Patel P, Malo S, Ray M, Abtahi M, Muhammad N, Raychowdhury A, Teshager A, Mohamed M, Moss K, Ahmed R, Hakimian S, Narisawa S, Mill\u00e1n L, Hohmann E, Warren S, Bhan K, Malo S, Hodin A (2013) Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Nat Acad Sci USA 110(17):7003\u20137008","journal-title":"Proc Nat Acad Sci USA"},{"issue":"12","key":"399_CR128","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.ebiom.2015.11.027","volume":"2","author":"S Malo","year":"2015","unstructured":"Malo S (2015) A high level of intestinal alkaline phosphatase is protective against Type 2 diabetes mellitus irrespective of obesity. EBioMedicine 2(12):2016\u20132023","journal-title":"EBioMedicine"},{"key":"399_CR129","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1210\/jcem.86.3.7327","volume":"86","author":"P Lips","year":"2001","unstructured":"Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:3008","journal-title":"J Clin Endocrinol Metab"},{"key":"399_CR130","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJM199803193381201","volume":"338","author":"M Thomas","year":"1998","unstructured":"Thomas M, Lloyd-Jones D, Thadhani R, Shaw A, Deraska D, Kitch B, Vamvakas E, Dick I, Prince R, Finkelstein J (1998) Hypovitaminosis D in medical inpatients. N Eng J Med 338:777\u2013783","journal-title":"N Eng J Med"},{"issue":"8","key":"399_CR131","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo C, Tonelli M, Thadhani R (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72(8):1004\u20131013","journal-title":"Kidney Int"},{"issue":"3","key":"399_CR132","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2215\/CJN.03790808","volume":"4","author":"V Belozeroff","year":"2009","unstructured":"Belozeroff V, Goodman W, Ren L, Kalantar-Zadeh K (2009) Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients. Clin J Am Soc Nephrol 4(3):673\u2013679","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5 Suppl 5","key":"399_CR133","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/ajkd.2001.28114","volume":"38","author":"F Llach","year":"2001","unstructured":"Llach F, Yudd M (2001) Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Am J Kidney Dis 38(5 Suppl 5):45\u201350","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"399_CR134","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","volume":"147","author":"S Palmer","year":"2007","unstructured":"Palmer S, McGregor D, Macaskill P, Craig J, Elder G, Strippoli F (2007) Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147(12):840\u2013853","journal-title":"Ann Intern Med"},{"issue":"9","key":"399_CR135","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/ndt\/gft227","volume":"28","author":"D Coyne","year":"2013","unstructured":"Coyne D, Andress D, Amdahl M, Ritz E, de Zeeuw D (2013) Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study. Nephrol Dial Transplant 28(9):2260\u20132268","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"399_CR136","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1681\/ASN.2004080694","volume":"16","author":"K Lomashvili","year":"2005","unstructured":"Lomashvili K, Khawandi W, O\u2019Neill C (2005) Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16(8):2495\u20132500","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"399_CR137","first-page":"327","volume":"4","author":"H Makar","year":"2010","unstructured":"Makar H, Sawires K, Farid M, Ali M, Schaalan M (2010) Effect of high-flux versus low-flux dialysis membranes on parathyroid hormone. Iran J Kidney Dis 4(4):327\u2013332","journal-title":"Iran J Kidney Dis"},{"key":"399_CR138","first-page":"1093","volume":"2","author":"A L\u00f3pez-Gonz\u00e1lez","year":"2010","unstructured":"L\u00f3pez-Gonz\u00e1lez A, Grases F, Perello J, Tur F, Costa A, Monroy N, Mari B, Vicente T (2010) Phytate levels and bone parameters: a retrospective pilot clinical trial. Front Biosci 2:1093\u20131098","journal-title":"Front Biosci"},{"key":"399_CR139","doi-asserted-by":"crossref","unstructured":"Grases F, Sanchis P, Perello J, Isern B, Prieto R, Fernandez-Palomeque C, Fiol M, Bonnin O, Torres J (2006). Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci, (11): 136\u2013142","DOI":"10.2741\/1786"},{"issue":"suppl 3","key":"399_CR140","doi-asserted-by":"publisher","first-page":"iii592","DOI":"10.1093\/ndt\/gfv199.13","volume":"30","author":"J Perell\u00f3","year":"2015","unstructured":"Perell\u00f3 J, Salcedo C, Joubert P, Canals A, Ferrer M (2015) First-time-in-human phase 1 clinical trial in healthy volunteers with SNF472, a novel inhibitor of vascular calcification. Nephrol Dial Transplant 30(suppl 3):iii592 (abstract)","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"399_CR141","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/ATVBAHA.114.304017","volume":"34","author":"R Jansen","year":"2014","unstructured":"Jansen R, Duijst S, Mahakena S, Sommer D, Szeri F, V\u00e1radi A, Plomp A, Bergen A, Oude R, Borst P, van de Wetering K (2014) ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. Arterioscler Thromb Vasc Biol 34(9):1985\u20131989","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"399_CR142","first-page":"1","volume":"5","author":"V Pomozi","year":"2016","unstructured":"Pomozi V, Brampton C, Szeri F, Dedinszki D, Koz\u00e1k E, van de Wetering K, Hopkins H, Martin L, V\u00e1radi A Le Saux (2016) Functional rescue of ABCC6 deficiency by 4-Phenylbutyrate therapy reduces dystrophic calcification in Abcc6-\/- Mice. J Invest Dermatol 5:1\u201325","journal-title":"J Invest Dermatol"},{"key":"399_CR143","first-page":"1","volume":"6","author":"R Albright","year":"2015","unstructured":"Albright R, Stabach P, Cao W, Kavanagh D, Mullen I, Braddock A, Covo M, Tehan M, Yang G, Cheng Z, Bouchard K, Yu Z, Thorn S, Wang X, Folta-Stogniew E, Negrete A, Sinusas A, Shiloach J, Zubal G, Madri J, De La Cruz E, Braddock D (2015) ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy. Albright Nature Commun 6:1\u201332","journal-title":"Albright Nature Commun"},{"issue":"5477","key":"399_CR144","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.289.5477.265","volume":"289","author":"A Ho","year":"2000","unstructured":"Ho A, Johnson M, Kingsley D (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289(5477):265\u2013270","journal-title":"Science"},{"issue":"1","key":"399_CR145","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1128\/MCB.25.1.312-323.2005","volume":"25","author":"W Wang","year":"2005","unstructured":"Wang W, Xu J, Du B, Kirsch T (2005) Role of the progressive ankylosis gene (ank) in cartilage mineralization. Molecular Cellular Biology 25(1):312\u2013323","journal-title":"Molecular Cellular Biology"},{"issue":"8","key":"399_CR146","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1359\/jbmr.060515","volume":"21","author":"K Gurley","year":"2006","unstructured":"Gurley K, Chen H, Guenther C, Nguyen E, Rountree R, Schoor M, Kingsley D (2006) Mineral formation in joints caused by complete or joint-specific loss of ANK function. J Bone Miner Res 21(8):1238\u20131247","journal-title":"J Bone Miner Res"},{"issue":"24","key":"399_CR147","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/CIRCULATIONAHA.112.000571","volume":"127","author":"R Villa-Bellosta","year":"2013","unstructured":"Villa-Bellosta R, Rivera-Torres J, Osorio F, Ac\u00edn-P\u00e9rez R, Enriquez J, L\u00f3pez-Ot\u00edn C, Andr\u00e9s V (2013) Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment. Circulation 127(24):2442\u20132451","journal-title":"Circulation"},{"issue":"2","key":"399_CR148","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00223-015-0020-7","volume":"97","author":"R Oliveira De","year":"2015","unstructured":"De Oliveira R, Louvet L, Riser B, Barreto F, Benchitrit J, Rezg R, Poirot S, Jorgetti V, Dr\u00fceke T, Massy Z (2015) Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice. Calcif Tissue Int 97(2):179 \u2013 92","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"399_CR149","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.bmcl.2016.01.061","volume":"26","author":"S Marqu\u00e9s","year":"2016","unstructured":"Marqu\u00e9s S, Buchet R, Popowycz F, Lemaire M, Mebarek S (2016) Synthesis of benzofuran derivatives as selective inhibitors of tissue-nonspecific alkaline phosphatase: effects on cell toxicity and osteoblast-induced mineralization. Bioorg Med Chem Lett 26(5):1457\u20131459","journal-title":"Bioorg Med Chem Lett"},{"issue":"49","key":"399_CR150","doi-asserted-by":"publisher","first-page":"19754","DOI":"10.1073\/pnas.1310658110","volume":"110","author":"S Picaud","year":"2013","unstructured":"Picaud S, Wells C, Felletar I, Brotherton D, Martin S, Savitsky P, Diez-Dacal B, Philpott M, Bountra C, Lingard H, Fedorov O, M\u00fcller S, Brennan E, Knapp S, Filippakopoulos P (2013) RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc Nat Acad Sci USA 110(49):19754\u201319759","journal-title":"Proc Nat Acad Sci USA"},{"key":"399_CR151","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2016.01.036","volume":"247","author":"D Gilham","year":"2016","unstructured":"Gilham D, Wasiak S, Tsujikawa L, Halliday C, Norek K, Patel R, Kulikowski E, Johansson J, Sweeney M, Wong N (2016) RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I\/HDL and represses pathways that contribute to cardiovascular disease. Atheroscler 247:48\u201357","journal-title":"Atheroscler"},{"key":"399_CR152","first-page":"227A","volume":"26","author":"K Kalantar-Zadeh","year":"2015","unstructured":"Kalantar-Zadeh K et al (2015) Alkaline phosphatase lowering by selective bet inhibition, a novel mechanism for mace reduction in high risk cvd, diabetes and CKD patients \u2014 a post-hoc analysis of phase 2b studies with RVX-208. J Am Soc Nephrol 26:227A","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 1","key":"399_CR153","doi-asserted-by":"publisher","first-page":"i109","DOI":"10.1093\/ndt\/gfw157.32","volume":"31","author":"N Wong","year":"2016","unstructured":"Wong N, Kalantar-Zadeh K, Kulikowski E, Wasiak S, Gilham D, Halliday C, Sweeney M, Johansson J (2016) SP071 Apabetalone (RVX-208), a selective bromodomain and extra-terminal (BET) protein inhibitor, decreases abundance and activity of complement proteins in vitro, in mice and in clinical studies. Nephrol Dial Transplant 31(suppl 1):i109","journal-title":"Nephrol Dial Transplant"},{"key":"399_CR154","unstructured":"Kausik R (Estimated study completion data October 2018). Phase A, Multi-Center III, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Clinical Trial in High-Risk Type 2 Diabetes Mellitus (T2DM) Subjects With Coronary Artery Disease (CAD) to Determine Whether Bromodomain Extraterminal Domain (BET) Inhibition Treatment With RVX000222 Increases. the Time to Major Adverse Cardiovascular Events (MACE)"},{"key":"399_CR155","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2014.11.017","volume":"72","author":"C Gasque","year":"2015","unstructured":"Gasque C, Foster L, Kuss P, Yadav C, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman J, Mill\u00e1n L (2015) Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-\/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Bone 72:137\u2013147","journal-title":"Bone"},{"issue":"9","key":"399_CR156","doi-asserted-by":"publisher","first-page":"e012371","DOI":"10.1136\/bmjopen-2016-012371","volume":"6","author":"E Peters","year":"2016","unstructured":"Peters E, Mehta L, Murray T, Hummel J, Joannidis M, Kellum A, Arend J, Pickkers P (2016) Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI). BMJ Open 6(9):e012371","journal-title":"BMJ Open"},{"issue":"20","key":"399_CR157","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1111\/bph.13261","volume":"172","author":"E Peters","year":"2015","unstructured":"Peters E, Geraci S, Heemskerk S, Wilmer J, Bilos A, Kraenzlin B, Gretz N, Pickkers P, Masereeuw R (2015) Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate. Br J Pharmacol 172(20):4932\u20134945","journal-title":"Br J Pharmacol"},{"key":"399_CR158","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.taap.2016.10.015","volume":"313","author":"E Peters","year":"2016","unstructured":"Peters E, Ergin B, Kandil A, Gurel-Gurevin E, van Elsas A, Masereeuw R, Pickkers P, Ince C (2016) Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury. Toxicol Appl Pharmacol 313:88\u201396","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"399_CR159","doi-asserted-by":"publisher","first-page":"20139","DOI":"10.3390\/molecules191220139","volume":"19","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, Gehr W, Ghosh S (2014) Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules 19(12):20139\u201320156","journal-title":"Molecules"},{"issue":"9","key":"399_CR160","first-page":"1","volume":"9","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, Bie J, Wang J, Ghosh S (2014) Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-\/- mice\u2013role of intestinal permeability and macrophage activation. PLoS One 9(9):e108577: 1\u20139","journal-title":"PLoS One"},{"issue":"4","key":"399_CR161","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"L Mill\u00e1n","year":"2016","unstructured":"Mill\u00e1n L, Whyte P (2016) Alkaline Phosphatase and Hypophosphatasia. Calcif Tissue Int 98(4):398\u2013416","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"399_CR162","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ki.2012.77","volume":"82","author":"S Sardiwal","year":"2012","unstructured":"Sardiwal S, Gardham C, Coleman A, Stevens P, Delaney M, Lamb E (2012) Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney Int 82(1):100\u2013105","journal-title":"Kidney Int"},{"issue":"2","key":"399_CR163","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2215\/CJN.09580911","volume":"8","author":"G Garrett","year":"2013","unstructured":"Garrett G, Sardiwal S, Lamb E, Goldsmith D (2013) PTH\u2013a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol 8(2):299\u2013312","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"399_CR164","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2215\/CJN.04650512","volume":"8","author":"S Sprague","year":"2013","unstructured":"Sprague S, Moe S (2013) The Case for Routine Parathyroid Hormone Monitoring. Clin J Am Soc Nephrol 8(2):313\u2013318","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"399_CR165","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2215\/CJN.09471209","volume":"5","author":"C Gardham","year":"2010","unstructured":"Gardham C, Stevens E, Delaney P, LeRoux M, Coleman A, Lamb J (2010) Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol 5(7):1261\u20131267","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-018-0399-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-018-0399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-018-0399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T10:13:56Z","timestamp":1660472036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-018-0399-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":165,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1007\/s00223-018-0399-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}